Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Shingyoji

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Internal Medicine (Tokyo, Japan)|March 7, 2015
Endobronchial ultrasound-guided transbronchial needle aspiration in a patient with pericardial mesotheliomaHironori Ashinuma, Masato Shingyoji, Yasushi Yoshida, et al.
Molecular Oncology|April 30, 2019
AMPK activation induced in pemetrexed-treated cells is associated with development of drug resistance independently of target enzyme expressionYiyang Qin, Ikuo Sekine, Michiko Hanazono, et al.
Cancer|February 6, 2003
Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinomaMasato Shingyoji, Yuichi Takiguchi, Reiko Watanabe, et al.
American Journal of Cancer Research|February 14, 2019
A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathwayBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Springerplus|July 21, 2015
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 geneYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
Cell Death & Disease|July 7, 2021
An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expressionThao Thi Thanh Nguyen, Masato Shingyoji, Michiko Hanazono, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2011
Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitisMasato Shingyoji, Hajime Kageyama, Tsukasa Sakaida, et al.
Radiation Research|June 22, 2005
Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: a comparative study of low and high dosesLiang-Hao Ding, Masato Shingyoji, Fanqing Chen, et al.
Springerplus|March 31, 2016
An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocolYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
BMC Cancer|July 14, 2016
Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesotheliomaYuanyuan Jiang, Boya Zhong, Kiyoko Kawamura, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Internal Medicine (Tokyo, Japan)|March 7, 2015
Endobronchial ultrasound-guided transbronchial needle aspiration in a patient with pericardial mesotheliomaHironori Ashinuma, Masato Shingyoji, Yasushi Yoshida, et al.
Molecular Oncology|April 30, 2019
AMPK activation induced in pemetrexed-treated cells is associated with development of drug resistance independently of target enzyme expressionYiyang Qin, Ikuo Sekine, Michiko Hanazono, et al.
Cancer|February 6, 2003
Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinomaMasato Shingyoji, Yuichi Takiguchi, Reiko Watanabe, et al.
American Journal of Cancer Research|February 14, 2019
A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathwayBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Springerplus|July 21, 2015
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 geneYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
Cell Death & Disease|July 7, 2021
An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expressionThao Thi Thanh Nguyen, Masato Shingyoji, Michiko Hanazono, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2011
Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitisMasato Shingyoji, Hajime Kageyama, Tsukasa Sakaida, et al.
Radiation Research|June 22, 2005
Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: a comparative study of low and high dosesLiang-Hao Ding, Masato Shingyoji, Fanqing Chen, et al.
Springerplus|March 31, 2016
An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocolYuji Tada, Kenzo Hiroshima, Hideaki Shimada, et al.
BMC Cancer|July 14, 2016
Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesotheliomaYuanyuan Jiang, Boya Zhong, Kiyoko Kawamura, et al.
Pageof 5